Signalling L5
Signaling Cascades in Practice
Presented by: Miriam Moriarty
Email: miriam.moriarty@universityofgalway.ie
Long-Term Potentiation (LTP)
Concept: "Cells that fire together wire together"
Key Components:
NMDA receptor
AMPA receptor
Calcium ions (Ca2+) involved in signaling
Tetanus stimulation at various intervals
Observations:
Changes in synaptic strength are measured over time
Parameters:
Resting potential: -70 mV
LTP response: +40 mV
Memory and the Hippocampus
Damage to the hippocampus leads to anterograde amnesia.
Pharmacological blockade of LTP also results in anterograde amnesia.
NMDA Receptor Structure
Recognition and functional sites within the NMDA receptor:
Polyamine site
Zn2+ site
Glutamate recognition site
Glycine site
Extra-/Intracellular components for ion interactions (Na+, Ca2+, Mg2+)
Mechanism of Short-term and Long-term LTP
Short-term LTP
Involves transient changes in synaptic strength
Location: Presynaptic and postsynaptic terminals
Long-term LTP
Activation of NMDA and AMPA receptors
Calcium entry and activation of synaptic growth proteins
Dendritic spines and kinase involvement
Key pathway: cAMP and PKA activation leading to CREB transcription
Calcium Signaling
Ca2+ enters through NMDA receptors
Ca2+ binds to calmodulin, activating CaMKII which subsequently activates adenylate cyclase
Results in conversion of ATP to cAMP, activating PKA, leading to CREB phosphorylation and new protein synthesis
Phases of Long-term Potentiation
Early Phase LTP:
Involves post-translational modifications, such as phosphorylation of existing AMPA receptors.
Late Phase LTP:
Requires transcriptional changes and synthesis of new proteins to facilitate synaptic growth and receptor substitution.
Retrograde Messengers
Function: Send signals back to the presynaptic cell
Characteristics: Small/lipophilic molecules (e.g., Nitric Oxide, Arachidonic Acid)
BDNF (Brain-Derived Neurotrophic Factor)
Role:
Involved in neuronal maturation, synapse formation, and synaptic plasticity
Implications: Associated with disorders like Schizophrenia and mood disorders.
Evidence: BDNF levels lower in depression; increase with antidepressant treatment.
BDNF on Depression
Signaling Pathways:
TrkB receptor activation
Involved pathways: Akt activation leading to inhibition of GSK3-beta and interaction with Wnt signaling
Neurotrophic hypothesis:
5-HT pathways stimulate BDNF transcription through CREB activation.
Mechanism of BDNF Signaling
BDNF signals through TrkB (tyrosine receptor kinase B)
Distinct pathways leading to survival and growth signaling.
Antidepressant Action
SSRIs and SNRIs increase BDNF expression
Indirect activation of pathways through stabilizing neurogenesis and modulating neurotransmitter systems.
Complexity of Interactions
Interplay between BDNF, serotonin, and various intracellular signaling processes necessitates a comprehensive understanding of psychiatric conditions and antidepressant mechanisms.
Conclusion
Signaling pathways and their outcomes illustrate the intricate relationship between neurobiology and mental health treatments.
Dotted line arrows in models indicate indirect effects (e.g., BDNF as a CREB target gene).
Emphasis on neurogenesis, synaptic plasticity, and their relevance in mood stabilization.